Full Text View
Tabular View
No Study Results Posted
Related Studies
Nicotinic Modulation of Schizophrenia-Like Information Processing Deficits in Healthy Subjects
This study is currently recruiting participants.
Study NCT00690170.   Last updated on May 30, 2008.
Information provided by Yale University
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Subjects
Additional conditions recognized in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Ketamine
Nicotine
Placebo
Ketamine and Nicotine
Additional drug interventions recognized in this trial
Nicotine polacrilex
More general drug interventions related to this trial
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Yale University


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services